Pharma group Krka posted record-high sales in 2023

Novo Mesto, 25 January - Pharma group Krka recorded 5% higher sales revenue last year compared to the year before, at EUR 1.81 billion, which is a new record, preliminary unaudited results show. Net profit was down 14% on 2022 due to foreign exchange losses, and amounted to an estimated EUR 311.2 million.

Krka's logo.
Photo: Katja Kodba/STA

The rest of this news item is available to subscribers.
The news item consists of 1.565 characters (without spaces) or 325 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2024